- Category
- Micro (2022-23)
- Udyam number
- UDYAM-BR-26-0073491

Aruh Pharmaceuticals Private Limited
About Aruh Pharmaceuticals Private Limited
Data last updated:
Aruh Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 05 September 2022.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24110BR2022PTC059792.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Rekha Kumari and Rajnish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Smt.Rekha Kumari W/O Sri Rajnish Kumar F/305 Ram Shyam Niketan, Patna, Bihar, India – 800013.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.85 Lakh, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹9,920 (net margin 0.4%) and EBITDA of ₹14,050 (EBITDA margin 0.5%).
Aruh Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0073491). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Aruh Pharmaceuticals
Contact details
Aruh Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressC/O Smt.Rekha Kumari W/O Sri Rajnish Kumar F/305 Ram Shyam Niketan, Patna, Bihar, India – 800013
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aruh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aruh Pharmaceuticals Private Limited, buy the company report.
Financials of Aruh Pharmaceuticals Private Limited
FY 2025 filings availableAruh Pharmaceuticals Private Limited reported revenue of ₹26.85 Lakh (up 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 76% in the latest year. EBITDA rose 112% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹14,050 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹9,920 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.5% | ||
| Net Profit Margin | 0.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aruh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aruh Pharmaceuticals Private Limited
Aruh Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Kumari | Director | 05 Sep 2022 | 4 Years 1 Months | Current |
| Rajnish Kumar | Director | 05 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Aruh Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aruh Pharmaceuticals Private Limitedthis company | ₹26.85 Lakh (FY 2025) | ₹9,920 | 0.4% | 76.0% | Patna, Bihar, India | |
| Viank Pharmaceuticals Private Limited | ₹26.82 Lakh (FY 2020) | 110.0% | Kolkata, West Bengal, India | |||
| Koyilandy Pharmaceuticals Private Limited | ₹26.78 Lakh (FY 2019) | -20.0% | Koyilandy, Kerala, India | |||
| Maxiss Pharmaceuticals Private Limited | ₹26.77 Lakh (FY 2023) | 291.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Aruh Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aruh Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aruh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aruh Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aruh Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rajnish Kumar was appointed as Director on 05 Sep 2022.
Frequently asked questions
Aruh Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 05 September 2022 (4+ years old) and is registered under CIN U24110BR2022PTC059792.
Aruh Pharmaceuticals has 2 current directors:
- Rekha Kumari - Director
- Rajnish Kumar - Director
The latest financial statements of Aruh Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Aruh Pharmaceuticals is U24110BR2022PTC059792. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aruh Pharmaceuticals was incorporated on 05 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Aruh Pharmaceuticals by revenue are Viank Pharmaceuticals Private Limited, Koyilandy Pharmaceuticals Private Limited, Maxiss Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajnish Kumar was appointed as Director on 05 Sep 2022. Rekha Kumari was appointed as Director on 05 Sep 2022.
Yes, Aruh Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0073491).
The registered office of Aruh Pharmaceuticals is at CO Smt.Rekha Kumari WO Sri Rajnish Kumar F305 Ram Shyam Niketan, Patna, Bihar, India – 800013.
Aruh Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
The compliance status of Aruh Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

